Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge
Article in Vaccine (August 2024)
The most recent citing publications are shown below. View all 95 publications that cite this research output on Dimensions.
Role of aptamer technology in extracellular vesicle biology and therapeutic applications
Article in Nanoscale (June 2024)
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study
Article in The Journal of Infectious Diseases (June 2024)